Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-24-023307

PRESIDENT AND CEO sold 30,000 shares at an average $59.13 ($1,773,790)

  • PRESIDENT AND CEO acquired 30,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Torley Helen · PRESIDENT AND CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-10 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $13.87 $138,700 686,744 D
2024-09-10 Sale : show line 2 in the form 10b5-1 −10,000 $59.09 $590,890 676,744 D
2024-09-11 Exercise or conversion : show line 3 in the form 10b5-1 +10,000 $13.87 $138,700 686,744 D
2024-09-11 Sale : show line 4 in the form 10b5-1 −10,000 $59.09 $590,870 676,744 D
2024-09-12 Exercise or conversion : show line 5 in the form 10b5-1 +10,000 $13.87 $138,700 686,744 D
2024-09-12 Sale : show line 6 in the form 10b5-1 −10,000 $59.20 $592,030 676,744 D
Open-market sales · 30,000 sh · avg $59.13 · $1,773,790

Table II: Derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-10 Exercise or conversion : show line 7 in the form 10b5-1 Option to Purchase Common Stock −10,000 $13.87 $138,700 70,000 D
2024-09-11 Exercise or conversion : show line 8 in the form 10b5-1 Option to Purchase Common Stock −10,000 $13.87 $138,700 60,000 D
2024-09-12 Exercise or conversion : show line 9 in the form 10b5-1 Option to Purchase Common Stock −10,000 $13.87 $138,700 50,000 D
Loading xslF345X05/form4-09122024_090954.xml…